| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 34.813 | 39.196 | 17.366 | 20.215 | 35.567 | 48.519 | 52.671 |
| Total Income - EUR | - | - | 0 | 34.813 | 39.196 | 17.366 | 20.215 | 35.568 | 48.519 | 52.672 |
| Total Expenses - EUR | - | - | 33 | 8.136 | 19.960 | 9.774 | 8.904 | 10.472 | 12.677 | 9.804 |
| Gross Profit/Loss - EUR | - | - | -33 | 26.677 | 19.237 | 7.591 | 11.311 | 25.097 | 35.842 | 42.868 |
| Net Profit/Loss - EUR | - | - | -33 | 26.146 | 18.845 | 7.070 | 10.717 | 24.293 | 29.754 | 36.007 |
| Employees | - | - | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nirmed Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 17.894 | 12.591 | 7.459 | 2.613 | 771 | 586 |
| Current Assets | - | - | 46 | 27.277 | 34.730 | 12.708 | 11.357 | 28.333 | 35.475 | 41.104 |
| Inventories | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 3 |
| Receivables | - | - | 0 | 9 | 0 | 0 | 12 | 1.230 | 30.267 | 39.570 |
| Cash | - | - | 46 | 27.268 | 34.729 | 12.708 | 11.344 | 27.102 | 5.205 | 1.531 |
| Shareholders Funds | - | - | 11 | 26.157 | 27.131 | 4.419 | 4.930 | 21.736 | 27.161 | 33.465 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 35 | 1.120 | 25.493 | 20.880 | 13.885 | 9.210 | 9.085 | 8.225 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Nirmed Consulting Srl